Cargando…
Cross-National Variation in Glycemic Control and Diabetes-Related Distress Among East Asian Patients Using Insulin: Results from the MOSAIc Study
INTRODUCTION: Guidelines recommend insulin progression for patients with type 2 diabetes (T2D) with inadequate glycemic control. The Multinational Observational Study Assessing Insulin use (MOSAIc [ClinicalTrials.gov identifier, NCT01400971]) study is a 2-year observational study, investigating fact...
Autores principales: | Matsuba, Ikuro, Sawa, Tasuku, Kawata, Takehiro, Kanamori, Akira, Jiang, Dingfeng, Machimura, Hideo, Takeda, Hiroshi, Han, Jeong Hee, Wang, Ke, Tanaka, Keiji, Shen, Li, Ajima, Miho, Kaneshiro, Mizuki, Kim, Sang-Wook, Umezawa, Shinichi, Asakura, Taro, Suzuki, Shuichi, Kim, Seoyoung C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900985/ https://www.ncbi.nlm.nih.gov/pubmed/27255328 http://dx.doi.org/10.1007/s13300-016-0178-7 |
Ejemplares similares
-
Multinational Observational Study to Understand Insulin Treatment Intensification: Japanese Subgroup Analysis of the MOSAIc Study
por: Matsuba, Ikuro, et al.
Publicado: (2022) -
Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus
por: Kawata, Takehiro, et al.
Publicado: (2017) -
Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study
por: Matsuba, Ikuro, et al.
Publicado: (2020) -
A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes
por: Takai, Masahiko, et al.
Publicado: (2020) -
Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study
por: Iemitsu, Kotaro, et al.
Publicado: (2016)